Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability. Mulato A, Lansdon E, Aoyama R, Voigt J, et al. Antimicrob Agents Chemother 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.

Read + Share

Amedeo Smart

Independent Medical Education

Mulato A, Lansdon E, Aoyama R, Voigt J, et al. Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability. Antimicrob Agents Chemother 2024 Feb 21:e0137323. doi: 10.1128/aac.01373.
PMID: 38380945